Related Experiment Video

Updated: Nov 4, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.0K

Current and effective strategies for critical reagent characterization, storage, stability, retesting and life cycle

Lakshmi Amaravadi1, Nisha Palackal2, Fabio Garofolo3

  • 1Boston Pharmaceuticals, Cambridge, MA, USA.

Bioanalysis
|May 26, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ADA assaysLBAPK assaysWRIBbiomarker assayscritical reagentsflow cytometryligand-binding assays

More Related Videos

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

14.0K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.0K

Related Experiment Videos

Last Updated: Nov 4, 2025

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.0K
A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
06:56

A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4

Published on: March 10, 2018

14.0K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.0K

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

14.7K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
14.7K

Articles linked to this work by shared authors, journal, and citation graph.

Vaccine Ligand Binding Assay Development.

Bioanalysis·2026

Vaccine Ligand Binding Assay Life Cycle Management, Assay Maintenance, Monitoring and Transfer.

Bioanalysis·2026

Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development.

Bioanalysis·2026

2025 White Paper on Recent Issues in Bioanalysis: What is the Future of Bioanalytical LIMS? AI/ML Integration in Bioanalysis; Tear Sample Collection; Radiolabeled Mass Balance Studies; Chiral Assays; Bioanalysis of Antibody-Oligonucleotide & Bicycle Drug Conjugates (PART 1A - Recommendations on Mass Spectrometry Assays, Chromatography, Sample Preparation and Regulated Bioanalysis Sampling, Validating, Analyzing & Reporting PART 1B - Regulatory Agencies' Input on Regulated Bioanalysis/BMV).

Bioanalysis·2026

2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV)).

Bioanalysis·2026

Best practices in the application of parallelism for biomarker assay validation.

The AAPS journal·2026

Bedside analysis of volatile organic compounds in exhaled human breath as non-invasive diagnostic tool for colon diseases.

Bioanalysis·2026

Development and pre-qualification of a facile and ultra-sensitive LRRK2 LC/MS assay using high-affinity unmodified immobilization for immunocapture: meet bioanalytical challenges and search practical solutions.

Bioanalysis·2026

Recent developments in microsampling for oligonucleotides and biologics bioanalysis.

Bioanalysis·2026

A review of microsampling techniques for the analysis of chemical threat agents in biological matrices.

Bioanalysis·2026

Glycosylation-based distinction of endogenous and recombinant complement factor H enables selective quantification in human plasma.

Bioanalysis·2026

Understanding Alzheimer's disease through biomarkers: pathology, progression, and clinical application.

Bioanalysis·2026

Precision and Trueness Verification of Routine Biochemistry Tests using CLSI EP15-A3.

Clinical laboratory·2026

Efficient separation of sperm and epithelial cells using optical trapping on a microfluidic device.

Forensic science international·2026

Rapid discovery of monoclonal antibodies via high-throughput single BCR affinity sequencing.

Nucleic acids research·2026

Making Ends Meet or Just Meeting at the Ends? Assessing End-to-End Distance in Folded RNA Sequences and Other Branched Structures.

Bulletin of mathematical biology·2026

Flow cytometry-based characterization of isolated human neutrophils: Evaluating viability, purity and defining a reference interval for basal activation in functional assays.

Journal of immunological methods·2026

Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies.

Bioanalysis·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us